Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 21, 2021

SELL
$70.31 - $77.77 $763,847 - $844,893
-10,864 Closed
0 $0
Q1 2021

Apr 26, 2021

BUY
$68.86 - $81.11 $55,501 - $65,374
806 Added 8.01%
10,864 $838,000
Q4 2020

Jan 13, 2021

BUY
$71.77 - $79.65 $69,903 - $77,579
974 Added 10.72%
10,058 $823,000
Q3 2020

Nov 02, 2020

BUY
$73.18 - $82.95 $26,783 - $30,359
366 Added 4.2%
9,084 $753,000
Q2 2020

Jul 21, 2020

SELL
$70.42 - $80.13 $6,267 - $7,131
-89 Reduced 1.01%
8,718 $674,000
Q1 2020

Apr 10, 2020

SELL
$63.36 - $87.82 $8,490 - $11,767
-134 Reduced 1.5%
8,807 $678,000
Q4 2019

Jan 15, 2020

BUY
$77.58 - $87.54 $36,772 - $41,493
474 Added 5.6%
8,941 $813,000
Q3 2019

Oct 30, 2019

BUY
$76.08 - $82.93 $644,169 - $702,168
8,467 New
8,467 $713,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $320B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Shulman De Meo Asset Management LLC Portfolio

Follow Shulman De Meo Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shulman De Meo Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Shulman De Meo Asset Management LLC with notifications on news.